Accolade Performance

ACCDDelisted Stock  USD 7.02  0.00  0.00%   
The firm shows a Beta (market volatility) of -3.13, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Accolade, are expected to decrease by larger amounts. On the other hand, during market turmoil, Accolade, is expected to outperform it. Accolade, right now shows a risk of 0.0%. Please confirm Accolade, jensen alpha, maximum drawdown, and the relationship between the coefficient of variation and sortino ratio , to decide if Accolade, will be following its price patterns.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Accolade has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Accolade, is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
  

Accolade, Relative Risk vs. Return Landscape

If you would invest  702.00  in Accolade on November 20, 2025 and sell it today you would earn a total of  0.00  from holding Accolade or generate 0.0% return on investment over 90 days. Accolade is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Accolade,, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  

Accolade, Target Price Odds to finish over Current Price

The tendency of Accolade, Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 7.02 90 days 7.02 
about 36.21
Based on a normal probability distribution, the odds of Accolade, to move above the current price in 90 days from now is about 36.21 (This Accolade probability density function shows the probability of Accolade, Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Accolade has a beta of -3.13. This suggests as returns on its benchmark rise, returns on holding Accolade are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Accolade, is expected to outperform its benchmark. Moreover Accolade has an alpha of 1.7176, implying that it can generate a 1.72 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Accolade, Price Density   
       Price  

Predictive Modules for Accolade,

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Accolade,. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Accolade,'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
7.027.027.02
Details
Intrinsic
Valuation
LowRealHigh
5.935.937.72
Details

Accolade, Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Accolade, is not an exception. The market had few large corrections towards the Accolade,'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Accolade, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Accolade, within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
1.72
β
Beta against Dow Jones-3.13
σ
Overall volatility
0.85
Ir
Information ratio 0.12

Accolade, Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Accolade, for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Accolade, can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Accolade, is not yet fully synchronised with the market data
Accolade, has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 414.29 M. Net Loss for the year was (99.81 M) with profit before overhead, payroll, taxes, and interest of 215.08 M.
Accolade currently holds about 330.63 M in cash with (16.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6.
Over 88.0% of the company shares are held by institutions such as insurance companies

Accolade, Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Accolade, Stock often depends not only on the future outlook of the current and potential Accolade,'s investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Accolade,'s indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding74.9 M
Cash And Short Term Investments237 M

Accolade, Fundamentals Growth

Accolade, Stock prices reflect investors' perceptions of the future prospects and financial health of Accolade,, and Accolade, fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Accolade, Stock performance.

About Accolade, Performance

By analyzing Accolade,'s fundamental ratios, stakeholders can gain valuable insights into Accolade,'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Accolade, has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Accolade, has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania. Accolade operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 2350 people.

Things to note about Accolade, performance evaluation

Checking the ongoing alerts about Accolade, for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Accolade, help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Accolade, is not yet fully synchronised with the market data
Accolade, has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 414.29 M. Net Loss for the year was (99.81 M) with profit before overhead, payroll, taxes, and interest of 215.08 M.
Accolade currently holds about 330.63 M in cash with (16.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.6.
Over 88.0% of the company shares are held by institutions such as insurance companies
Evaluating Accolade,'s performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Accolade,'s stock performance include:
  • Analyzing Accolade,'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Accolade,'s stock is overvalued or undervalued compared to its peers.
  • Examining Accolade,'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Accolade,'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of Accolade,'s management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Accolade,'s stock. These opinions can provide insight into Accolade,'s potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Accolade,'s stock performance is not an exact science, and many factors can impact Accolade,'s stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Accolade, Stock

If you are still planning to invest in Accolade, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accolade,'s history and understand the potential risks before investing.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format